02 Dec 2020
Biotech experience of the rapid and nimble acceleration of clinical programmes in the light of Covid-19
- When a vaccine leaves the laboratory, its fate is determined by society rather than science
- All disease outbreaks are accompanied by outbreaks of fear, moralization and action
- How can you design vaccines to avoid provoking or amplifying fears?
- Avoid ‘deficit thinking’ about the intended recipients of the vaccine
- Mitigating COVID-19 risks with virtualization methods